Trial Profile
Phase I trial of BI 204 in patients with elevated LDL cholesterol levels.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Jul 2010
Price :
$35
*
At a glance
- Drugs Orticumab (Primary)
- Indications Atherosclerosis; Cardiovascular disorders; Hyperlipidaemia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors BioInvent International